6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
37m ago	Nayax to Report 2026 Q1 Earnings on May 12, 2026
1h ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

About

Foghorn Therapeutics Inc (NASDAQ:FHTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium

Financials

Revenue

$30.91 M

Market Cap

$286.46 M

EPS

-1.18

Community Chat

Ask AI